Editorial: Women in science: pharmacological treatment of pain
Uložené v:
| Názov: | Editorial: Women in science: pharmacological treatment of pain |
|---|---|
| Autori: | Araya, Erika, Chichorro, Juliana |
| Prispievatelia: | Institut Català de la Salut, [Araya EI] Grup de Recerca en Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Chichorro JG] Department of Pharmacology, Biological Sciences Sector, Federal University of Parana, Curitiba, Brazil, Vall d'Hebron Barcelona Hospital Campus |
| Zdroj: | Front Pain Res (Lausanne) Scientia Scientia. Dipòsit d'Informació Digital del Departament de Salut instname Frontiers in Pain Research, Vol 4 (2023) |
| Informácie o vydavateľovi: | Frontiers Media SA, 2023. |
| Rok vydania: | 2023 |
| Predmety: | ketamine, Other subheadings::Other subheadings::/therapeutic use, DISEASES::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Neurologic Manifestations::Pain::Chronic Pain, Pain Research, Other subheadings::Other subheadings::/therapy, Otros calificadores::Otros calificadores::/uso terapéutico, LPAR5 antagonist, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Central Nervous System Depressants::Anesthetics, Dolor crònic - Tractament, 3. Good health, CR4056, Otros calificadores::Otros calificadores::/terapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::depresores del sistema nervioso central::anestésicos, depression, lidocaine, Neurology. Diseases of the nervous system, ENFERMEDADES::afecciones patológicas, signos y síntomas::signos y síntomas::manifestaciones neurológicas::dolor::dolor crónico, chronic pain, RC346-429, Anestèsics - Ús terapèutic |
| Popis: | This study showed that both ketamine and lidocaine infusion was able to reduce mean daily morphine consumption by 28% and 23%, respectively. This finding provided a useful therapeutic approach to improve analgesia and decrease opioid consumption, which may be extremely relevant, especially for patients in need of long-term opioid use. JGC is recipient of a research productivity fellowship from CNPq (National Council for Scientific and Technological Development, Brazil). Chronic pain; Depression; Ketamine Dolor crónico; Depresión; Ketamina Dolor crònic; Depressió; Ketamina |
| Druh dokumentu: | Article Other literature type |
| Popis súboru: | application/pdf |
| ISSN: | 2673-561X |
| DOI: | 10.3389/fpain.2023.1231281 |
| Prístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/37441271 https://hdl.handle.net/11351/10114 https://doaj.org/article/74ccd9c3b2944d818a7ff7228894939e |
| Rights: | CC BY |
| Prístupové číslo: | edsair.doi.dedup.....c1b81132b3f79001c440e6b9c857d590 |
| Databáza: | OpenAIRE |
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | This study showed that both ketamine and lidocaine infusion was able to reduce mean daily morphine consumption by 28% and 23%, respectively. This finding provided a useful therapeutic approach to improve analgesia and decrease opioid consumption, which may be extremely relevant, especially for patients in need of long-term opioid use.<br />JGC is recipient of a research productivity fellowship from CNPq (National Council for Scientific and Technological Development, Brazil).<br />Chronic pain; Depression; Ketamine<br />Dolor crónico; Depresión; Ketamina<br />Dolor crònic; Depressió; Ketamina |
|---|---|
| ISSN: | 2673561X |
| DOI: | 10.3389/fpain.2023.1231281 |